Probiotics: Multifarious oral vaccine against infectious traumas

FEMS Immunology and Medical Microbiology

Volumn 58, Issue 3, 2010, Pages 299-306

  Amdekar, Sarika ^a   Dwivedi, Deepak ^a   Roy, Purabi ^a   Kushwah, Sapna ^a   Singh, Vinod ^a  

^a BARKATULLAH UNIVERSITY   (India)

Author keywords

Immunomodulation; Oral vaccine; Probiotics

Indexed keywords

2 NITROIMIDAZOLE; BACTERIAL VACCINE; GAMMA INTERFERON; IMMUNOGLOBULIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; LIVE VACCINE; MEROZOITE SURFACE PROTEIN 1; PROBIOTIC AGENT; RECOMBINANT VACCINE; TOLL LIKE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AEROCOCCUS; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; BACILLUS SUBTILIS; BACTERIAL COLONIZATION; BIFIDOBACTERIUM BIFIDUM; CYTOKINE PRODUCTION; DIGESTION; ENTEROCOCCUS; ENZYME RELEASE; GASTRITIS; GENE EXPRESSION; HELICOBACTER PYLORI; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; INFANTILE DIARRHEA; INFECTION; INFECTION PREVENTION; INTESTINE ABSORPTION; INTESTINE FLORA; INTESTINE LYMPHATIC TISSUE; ISCHEMIC HEART DISEASE; LACTIC ACID BACTERIUM; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS CASEI; LACTOBACILLUS DELBRUECKII; LACTOBACILLUS GASSERI; LACTOBACILLUS REUTERI; LACTOCOCCUS; LEUCONOSTOC; LISTERIA MONOCYTOGENES; MACROPHAGE; MALARIA; MUCOSAL IMMUNITY; NONHUMAN; NUTRIENT UPTAKE; PEDIOCOCCUS; PEPTIC ULCER; PLASMODIUM; PRIORITY JOURNAL; PROPIONIBACTERIUM; PROPIONIBACTERIUM FREUDENREICHII; ROTAVIRUS; SACCHAROMYCES; SALMONELLA ENTERICA; SALMONELLA TYPHI; SHIGELLA FLEXNERI; SHORT SURVEY; STOMACH ADENOCARCINOMA; TRICHOMONIASIS; TYPHOID FEVER; VACCINATION; VACCINE PRODUCTION; VIBRIO CHOLERAE;

ADMINISTRATION, ORAL; ANIMALS; COMMUNICABLE DISEASES; HUMANS; INFECTION; INTESTINES; LACTOBACILLUS; MICE; PROBIOTICS; VACCINES;

EID: 77949360853     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2009.00630.x     Document Type: Short Survey

References (70)

1. Akira S, Takeda K & Kaisho T (2001) Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2: 675-680.
2. Aldovini A &Young RA (1991) Humoral and cell-mediated immune response to live recombinant BCG-HIV vaccines. Nature 351: 479-482.
3. Anderson EJ & Weber SG (2004) Rotavirus infection in adults. Lancet Infect Dis 4: 91-99.
4. Benyacoub J, Hopkins S, Potts A, Kelly S, Kraehenbuhl JP, Curtiss R III, De Grandi P & Nardelli-Haefliger D (1999) The nature of the attenuation of Salmonella typhimurium strains expressing human papilloma virus type 16 virus-like particles determines the systemic and mucosal antibody responses in nasally immunized mice. Infect Immun 67: 3674-3679.
5. Bernet MF, Brassart D, Neeser JR & Servin AL (1994) Lactobacillus acidophilus LA1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria. Gut 35: 483-489.
6. Blackman MJ, Ling IT, Nicholls SC & Holder AA (1991) Proteolytic processing of the Plasmodium falciparum merozoite surface protein-1 produces a membrane-bound fragment containing two epidermal growth factor-like domains. Mol Biochem Parasit 49: 29-33.
7. Casas IA & Dobrogosz WJ (1997) Lactobacillus reuteri: overview of a new probiotic for humans and animals. Microecol Ther 26: 221-231.
8. Chukeatirote E (2003) Potential use of probiotics. Songklanakarin J Sci Technol 25: 275-282.
9. Classen E, Van Vinsen R, Posko M & Boersma WAU (1995) New and safe 'oral' live vaccines based on Lactobacillus. Adv Exp Med Biol 371B: 1553-1558.
10. Detme A & Glenting J (2006) Live bacterial vaccines - a review and identification of potential hazards. Microb Cell Fact 5: 23.
11. Dietrich G, Griot-Wenk M, Metcalfe IC, Lang AB & Viret JF (2003) Experience with registered mucosal vaccines. Vaccine 21: 678-683.
12. Donohue DC & Salminen S (1996) Safety of probiotic bacteria. Asia Pac J Clin Nutr 5: 25-28.
13. Elmer GW (2001) Probiotics: 'living drugs'. Am J Health Syst Ph 58: 1101-1109.
14. Fuller R (1989) Probiotics in man and animals. J Appl Bacteriol 66: 365-378.
15. Fuller R (1991) Probiotics in human medicine. Gut 32: 439-442.
16. Goldin BR, Gorbach SL, Saxelin M, Barakat S, Gualtieri L & Salminen S (1992) Survival of Lactobacillus species (strain GG) in human gastrointestinal tract. Digest Dis Sci 37: 121-128.
17. Gomboova A, Deme P & Valent M (1986) Immunotherapeutic effect of the lactobacillus vaccine, Solco Trichovac, in trichomoniasis is not mediated by antibodies cross reacting with Trichomonas vaginalis. Genitourin Med 62: 107-10.
18. Gonzalez SN, Cardoza R, Apella MC & Oliver G (1995) Biotherapeutic role of fermented milk. Biotherapy 8: 129-134.
19. Goodwin JS (1995) Decreased immunity and increased morbidity in the elderly. Nutr Rev 53: S41-S46.
20. Greene JD & Klaenhammer TR (1994) TLR factors involved in adherence of Lactobacilli to human Caco-2 cells. Appl Environ Microb 60: 4487-4494.
21. Havenaar R, Ten Brink B & Huis In't Veld JHJ (1992) Selection of strains for probiotic use. Probiotics, the Scientific Basis (Fuller R, ed.), pp. 209-224. Chapman & Hall, London.
22. Holder AA & Freeman RR (1981) Immunization against bloodstage rodent malaria using purified parasite antigens. Nature 294: 361-364.
23. Holzapfel WH, Haberer P, Snel J, Schillinger U & Huis In't Veld JH (1998) Overview of gut flora and probiotics. Int J Food Microbiol 41: 85-101.
24. Isolauri E, Juntunen M, Rautanen T, Sillanaukee P & Koivula T (1991) A human Lactobacillus strain (Lactobacillus casei sp. strain GG) promotes recovery from acute diarrhea in children. Pediatrics 88: 90-97.
25. Jack RW, Tagg JR & Ray B (1994) Bacteriocins of grampositive bacteria. Microbiol Rev 59: 171-200.
26. Kajikawa AE, Satoh RJ, Leer S, Yamamoto S & Igimi S (2007) Intragastric immunization with recombinant Lactobacillus casei expressing flagellar antigen confers antibody-independent protective immunity against Salmonella enterica serovar Enteritidis. Vaccine 25: 3599-3605.
27. Ke-Qin X, Yuka H, Yoshihiko T et al. (2003) Immunogenicity and protective efficacy of orally administered recombinant Lactococcus lactis expressing surface-bound HIV Env. Blood 102: 223-229.
28. Khansari DN, Murgo AJ & Faith AE (1990) Effects of stress on the immune system. Immunol Today 11: 170-175.
29. Kirjavainen PE, Ouwehand AC, Isolauri E & Salminen SJ (1998) The ability of probiotic bacteria to bind to human intestinal mucus. FEMS Microbiol Lett 167: 185-189.
30. Klijn N, Weerkamp AH & de Vos WM(1995) Genetic marking of Lactococcus lactis shows its survival in the human gastrointestinal tract. Appl Environ Microb 61: 2771-2774.
31. Kochi SK, Killeen KP & Ryan US (2003) Advances in the development of bacterial vector technology. Expert Rev Vaccines 74: 31-43.
32. Korik LM, Ljubimova LK & Tovstolec KP (1968) Immediate and remote results of treatment of trichomonosis in men with trichomonal vaccine. Vestn Dermatol Vener 42: 80-84.
33. Kotloff KL, Noriega F, Losonsky GA, Sztein MB, Wasserman SS, Nataro JP & Levine MM (1996) Safety, immunogenicity, and transmissibility in humans of CVD 1203, a live oral Shigella flexneri 2a vaccine candidate attenuated by deletions in aroA and virG. Infect Immun 64: 4542-4548.
34. Kukreja RC, Kontos MC & Hess ML (1996) Free radicals and heat shock protein in the heart. Ann NY Acad Sci 793: 108-122.
35. Lilly DM & Stillwell RH (1965) Probiotics: growth promoting factors produced by microorganisms. Science 147: 747-748.
36. Lin SY & Chen CT (2000) Reduction of cholesterol by Lactobacillus acidophilus in culture broth. J Food Drug Anal 8: 97-102.
37. Lin SY, Ayres JW, Winkler W & Sandine WE (1989) Lactobacillus effects on cholesterol: in vitro and in vivo results. J Dairy Sci 72: 2885-2899.
38. Lindberg AA (1995) The history of live bacterial vaccines. Dev Biol Stand 84: 211-219.
39. Lindberg AA (1998) Vaccination against enteric pathogens: from science to vaccine trials. Curr Opin Microbiol 1: 116-124.
40. Link-Amster H, Rochat F, Saudan K, Mignot O & Aeschlimann J (1994) Modulation of a specific humoral immune response and changes in intestinal flora mediated through fermented milk. FEMS Immunol Med Mic 10: 55-63.
41. Matsuzak T & Chin J (2000) Modulating immune response with probiotic bacteria. Immunol Cell Biol 78: 67-73.
42. Mattingly J &Waksman B (1978) Immunologic suppression after oral administration of antigen I specific suppressor cells formed in rat Peyer's patches after oral administration of sheep erythrocytes and their systemic migration. J Immunol 121: 1878-1883.
43. McGhee JR, Mestecky J, Dertzbaugh MT, Eldridge JH, Hirasawa M & Kiyono H (1992) The mucosal immune system: from fundamental concepts to vaccine development. Vaccine 10: 75-88.
44. Mercenier A, Muller-Alouf H & Grangette C (2000) Lactic acid bacteria as live vaccines. Curr Issues Mol Biol 2: 17-25.
45. Methnikoff E (1908) The Prolongation of Life, pp. 151-183. GP Putnam & Sons, New York.
46. Miller LH, Roberts T, Shahabuddin M & McCutchan TF (1993) Analysis of sequence diversity in the Plasmodium falciparum merozoite surface protein-1 (MSP-1). Mol Biochem Parasit 59: 1-14.
47. Morimoto RI & Santoro MG (1998) Stress-inducible responses and heat shock proteins: new pharmacologic targets for cytoprotection. Nat Biotechnol 16: 833-838.
48. Nardelli-Haefliger D, Kraehenbuhl R, Curtiss F III, Schodel A, Potts S, Kelly S & De Grandi P (1996) Oral and rectal immunization of adult female volunteers with a recombinant attenuated Salmonella typhi vaccine strain. Infect Immun 64: 5219-5224.
49. Netherwood T, Gilbert HJ, Parker DS & O' Donnell AG (1999) Probiotics shown to change bacterial community structure in the avian gastrointestinal tract. Appl Environ Microb 65: 5134-5138.
50. Neutra M & Krahenbuhl J (1996)Mcells as a pathway for antigen uptake and processing. Essentials of Mucosal Immunology, Vol. 2 (Kagnoff M & Kiyono H, eds), pp. 29-36. Academic Press Inc., New York.
51. Ouwehand AC, Kirjavainen PV, Gronlund MM, Isolauri E & Salminen S (1999) Adhesion of probiotic micro-organisms to intestinal mucus. Int Dairy J 9: 623-630.
52. Pawelec G, Adibzadeh M, Pohla H & Schaudt K (1995) Immunosenescence: aging of the immune system. Immunol Today 16: 420-422.
53. Perdigón G & Alvarez S (1992) Probiotics and the immune state. Probiotics. The Scientific Basis, Vol. 7 (Fuller R, ed.), pp. 145-180. Chapman & Hall, London.
54. Phillips-Quagliata J & Lamm M (1988) Migration of lymphocytes in the mucosal immune system. Migration and Homing of Lymphoid Cells (Husband A, ed.), pp. 53-75. CRC Press, Boca Raton.
55. Reid G (1999) The scientific basis for probiotic strains of Lactobacillus. Appl Environ Microb 65: 3763-3766.
56. Reid G & Burton J (2002) Use of Lactobacillus to prevent infection by pathogenic bacteria. Microbes Infect 4: 319-324.
57. Reid G, Servin A, Bruce AW & Busscher HJ (1993) Adhesion of three Lactobacillus strains to human urinary and intestinal epithelial cells. Songklanakarin J Sci Technol Microbios 75: 57-65.
58. Salimen S, Isolauri E & Salimen E (1996) Probiotics for stabilising the gut mucosal barrier: successful strains and future challenges. Antonie van Leeuwenhoek 70: 347-358.
59. Salminen S, Deighton MA, Benno Y & Gorbach SL (1998) Lactic acid bacteria in health and disease. Lactic acid bacteria: microbiology and functional aspects (Salminen S & von Wright A, eds), pp. 211-253. Marcel Dekker Inc, New York.
60. Sarem-Damerdjii LO, Sarem F, Marchal L & Nicolas JP (1995) In vitro colonisation ability of human colon mucosa by exogenous Lactobacillus strains. FEMS Microbiol Lett 131: 133-137.
61. Schnell MJ, Foley HD, Siler CA, Mc Gettigan JP, Dietzachold B & Pomerantz RJ (2000) Recombinant rabies virus as potential live-viral vaccines for HIV-1. P Natl Acad Sci USA 97: 3544-3549.
62. Shornikova AV, Casas A, Mykkanen H, Salo E & Vesikari T (1997) Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis. Pediatr Infect Dis J 16: 1103-1107.
63. Singh V, Singh K, Amdekar S, Singh DD, Tripathi P, Sharma GL & Yadav H (2008) Innate and specific gut-associated immunity and microbial interference. FEMS Immunol Med Mic 55: 6-12.
64. Strobel S (1995) Oral tolerance: Mucosal immunity and the gut epithelium: interactions in health and disease. Dyn Nutr Res 4: 65-75.
65. Tahri K, Grill JP & Schneider F (1996) Bifidobacteria strain behavior toward cholesterol: coprecipitation with bile salts and assimilation. Curr Microbiol 33: 187-193.
66. Tatyana O, Michal S, Adriana D, Klein R, Natalie A & Babeth R (2000) A new method of long-term preventive cardioprotection using Lactobacillus. Am J Physiol Heart C 278: 1717-1724.
67. Underdahl H, Torres Medina A & Doster A (1982) Effect of Streptococcus faecium C-68 in control of Escherichia coli induced diarrhea in gnotobiotic pigs. Am J Vet Res 43: 2227-2232.
68. Velazquez FR, Matson DO, Calva JJ, Guerrero SL, Morrow AL, Carter-Campbell S, Glass RI, Estes MK, Pickering LK & Ruiz-Palacios GM (1996) Rotavirus infections in infants as protection against subsequent infections. New Engl J Med 335: 1022-1028.
69. Weissman D, Ni H, Scales D, Dude A, Capodici J, Mcgibney K, Abdool A, Isaacs S, Cannon G & Kariko K (2000) HIV gag mRNA transfection of dendritic cells (DC) delivers encoded antigen to MHC class I and II molecules, causes DC maturation, and induces a potent human in vitro primary immune response. J Immunol 165: 4710-4717.
70. Woodward B (1998) Protein, calories and immune defenses. Nutr Rev 56: S84-S92.